DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Hormonal Factors in the Treatment of Anorexia Nervosa

Phase 2

Completed

Conditions: Anorexia Nervosa
Eating Disorder
Anxiety
Depression

Interventions: Drug: Placebo
Drug: Testosterone

First Posted Date: 2010-05-12

Last Posted Date: 2020-09-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 90

Registration Number: NCT01121211

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Duloxetine for Menopausal Depression

Phase 4

Completed

Conditions: Depression
Vasomotor Symptoms
Menopause

Interventions: Drug: Duloxetine

First Posted Date: 2010-05-06

Last Posted Date: 2014-08-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 29

Registration Number: NCT01117857

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Impact of Hot Flashes on Sleep and Mood Disturbance

Phase 4

Completed

Conditions: Menopause
Hot Flashes
Depression

Interventions: Drug: leuprolide

First Posted Date: 2010-05-05

Last Posted Date: 2018-01-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 29

Registration Number: NCT01116401

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders

Not Applicable

Completed

Conditions: Gastrointestinal Symptoms
Autism

Interventions: Other: GFCF product with GFCF diet
Other: product containing gluten and casein (milk protein) with GFCF diet

First Posted Date: 2010-05-05

Last Posted Date: 2015-04-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 65

Registration Number: NCT01116388

Locations: 🇺🇸
Baylor College of Medicine / Texas Children's Hospital, Houston, Texas, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies

Active, not recruiting

Conditions: Brain Tumors
Non-CNS Malignancies

Interventions: Other: Quality of Life surveys completed at specified timepoints

First Posted Date: 2010-05-04

Last Posted Date: 2019-12-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 600

Registration Number: NCT01115777

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Training in the Workplace

Not Applicable

Completed

Conditions: Healthy Individuals

Interventions: Behavioral: Program 2
Behavioral: Program 1

First Posted Date: 2010-04-30

Last Posted Date: 2014-11-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 75

Registration Number: NCT01113944

Locations: 🇺🇸
Massachusettts General Hospital, Boston, Massachusetts, United States

Role of Beta-Endorphin in Cancer Therapy Fatigue

Terminated

Conditions: Fatigue
Breast Cancer

First Posted Date: 2010-04-30

Last Posted Date: 2014-08-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 18

Registration Number: NCT01113905

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Phase 2

Completed

Conditions: Glioblastoma
GBM
Glioblastoma Multiforme

Interventions: Drug: PF-00299804

First Posted Date: 2010-04-28

Last Posted Date: 2018-08-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 58

Registration Number: NCT01112527

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States

and more 1 locations

Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract

Not Applicable

Completed

Conditions: Colorectal Polyps
Distal Colonic Lesions
High Risk Polyposis Syndrome

Interventions: Drug: indocyanine green

First Posted Date: 2010-04-28

Last Posted Date: 2014-02-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4

Registration Number: NCT01112514

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Evaluating Tumor Pseudoprogression With FLT-PET and MRI

Early Phase 1

Terminated

Conditions: Glioblastoma

First Posted Date: 2010-04-19

Last Posted Date: 2012-01-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2

Registration Number: NCT01105988

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy